PINKSimplify Health Care ETF
Seeks long-term capital appreciation.
By Simplify Asset Management · Launched 2021
Annual Cost
0.51%
#2,794 of 5,854 · average
Fund Size
$359M
#1,852 of 5,854 · large
Return (1Y)Goal
+31.7%
Track Record
4 years
#2,458 of 5,854 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$13,425+34.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Active selection
Factor
Growth
Sector
Health careWhat it actually holds
By weightConcentration
Top 10 holdings = 53.8% of fundmoderately concentrated
United Therapeutics Corporation
8.8%
Align Technology Inc.
7.9%
Eli Lilly & Co.
6.6%
Chugai Pharmaceutical Co Ltd.
5.2%
Novo Nordisk A/S
5.2%
AbbVie Inc.
4.6%
Jazz Pharmaceuticals PLC
4.2%
PURECYCLE TECHNOLOGIES INC
4.0%
Thermo Fisher Scientific Inc
3.7%
Gilead Sciences Inc.
3.7%
Asset allocation
Stocks
99.5%
Cash
0.5%
By sector
Healthcare
92.7%
Industrials
7.3%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
18.7%Moderate
Year-on-year price swings
Max drawdown
-18.8%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.62Decent risk-adjusted returns
Sortino (3Y)
0.90Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Invests primarily in securities of U.S. health care companies across all capitalizations, following a growth investment strategy while also considering value opportunities. Targets companies developing effective medicines and improving health care quality.
- Inception date
- October 7, 2021
- Fund family
- Simplify Asset Management
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at PINK. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03